EA201270544A1 - Композиции с отсроченным высвобождением - Google Patents

Композиции с отсроченным высвобождением

Info

Publication number
EA201270544A1
EA201270544A1 EA201270544A EA201270544A EA201270544A1 EA 201270544 A1 EA201270544 A1 EA 201270544A1 EA 201270544 A EA201270544 A EA 201270544A EA 201270544 A EA201270544 A EA 201270544A EA 201270544 A1 EA201270544 A1 EA 201270544A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
extended delivery
pharmaceutical compositions
coating
contain
Prior art date
Application number
EA201270544A
Other languages
English (en)
Russian (ru)
Inventor
Давид Исаак Сильвер
Джулия Храковски
Роэй Соломонович
Дафна Ариели
Original Assignee
Тева Фармасьютикал Индастриз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тева Фармасьютикал Индастриз Лтд. filed Critical Тева Фармасьютикал Индастриз Лтд.
Publication of EA201270544A1 publication Critical patent/EA201270544A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
EA201270544A 2009-10-13 2009-10-13 Композиции с отсроченным высвобождением EA201270544A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/060551 WO2011046546A1 (fr) 2009-10-13 2009-10-13 Compositions à libération retardée

Publications (1)

Publication Number Publication Date
EA201270544A1 true EA201270544A1 (ru) 2012-09-28

Family

ID=41683056

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270544A EA201270544A1 (ru) 2009-10-13 2009-10-13 Композиции с отсроченным высвобождением

Country Status (4)

Country Link
EP (1) EP2488173A1 (fr)
EA (1) EA201270544A1 (fr)
IL (1) IL218947A0 (fr)
WO (1) WO2011046546A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2950822B1 (fr) * 2013-01-30 2019-04-24 Daewoong Co., Ltd. Composition pharmaceutique pour la protection des plaies, l'hémostase, ou la prévention d'adhérence dans le tractus gastro-intestinal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) * 2003-01-20 2003-02-19 Novartis Ag Organic compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
KR20080094788A (ko) * 2006-02-13 2008-10-24 노파르티스 아게 고복용량의 미코페놀산(엠피에이)
BRPI0816231A2 (pt) * 2007-08-13 2015-06-16 Panacea Biotec Ltd Composições de liberação prolongada compreendendo micofenolato de sódio e seus processos
AR068745A1 (es) * 2007-10-08 2009-12-02 Panacea Biotec Ltd Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos

Also Published As

Publication number Publication date
EP2488173A1 (fr) 2012-08-22
IL218947A0 (en) 2012-07-31
WO2011046546A1 (fr) 2011-04-21

Similar Documents

Publication Publication Date Title
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
EA201170227A1 (ru) Имидазолкарбоксамиды
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
WO2012077120A3 (fr) Formulations naturelles
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
MX2012007507A (es) Compuestos de heteroarilo y usos de los mismos.
EA200802008A1 (ru) Фармацевтические композиции
EA201100268A1 (ru) Вакцина
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
MX350447B (es) Composicion farmaceutica de disolucion rapida.
EA201270590A1 (ru) Ингибиторы акт
MX2013002422A (es) Sales de lorcaserina con acidos opticamente activos.
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
TW200942530A (en) Pyridine compounds
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
MX2013007230A (es) Sistemas de polimero.
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
UA103996C2 (en) Ivabradine hydrobromide
WO2012080641A8 (fr) Agonistes des recepteurs s1p et leur utilisation dans le traitement des infections du vih
CO6761388A2 (es) Composiciones pharmaceuticas que comprenden alisporivir